101 related articles for article (PubMed ID: 7683934)
1. Immunoregulatory cytokine production by tumor-bearing rat spleen cells and its modulation by bleomycin.
Micallef M
Anticancer Drugs; 1993 Apr; 4(2):213-22. PubMed ID: 7683934
[TBL] [Abstract][Full Text] [Related]
2. Host-mediated therapeutic effects produced by appropriately timed administration of bleomycin on a rat fibrosarcoma.
Morikawa K; Hosokawa M; Hamada J; Sugawara M; Kobayashi H
Cancer Res; 1985 Apr; 45(4):1502-6. PubMed ID: 2579730
[TBL] [Abstract][Full Text] [Related]
3. Host immune responses to tumor cells augmented by bleomycin and their therapeutic effects on rat fibrosarcoma.
Hosokawa M; Xu ZY; Morikawa K; Hamada J; Kobayashi H
Mol Biother; 1988; 1(2):74-80. PubMed ID: 2479397
[TBL] [Abstract][Full Text] [Related]
4. [Enhancement of T cell-mediated immune responses in KMT-17-bearing rats by treatment with bleomycin].
Xu ZY
Hokkaido Igaku Zasshi; 1987 Mar; 62(2):279-88. PubMed ID: 2440789
[TBL] [Abstract][Full Text] [Related]
5. Restoration of interleukin-2 production in tumor-bearing rats through reducing tumor-derived transforming growth factor beta by treatment with bleomycin.
Yuan L; Kuramitsu Y; Li Y; Kobayashi M; Hosokawa M
Cancer Immunol Immunother; 1995 Dec; 41(6):355-62. PubMed ID: 8635193
[TBL] [Abstract][Full Text] [Related]
6. [Enhancement of antitumor immune responses by bleomycin].
Morikawa K
Hokkaido Igaku Zasshi; 1988 Sep; 63(5):772-80. PubMed ID: 2467868
[TBL] [Abstract][Full Text] [Related]
7. A new synthetic lipid A analog, ONO-4007, stimulates the production of tumor necrosis factor-alpha in tumor tissues, resulting in the rejection of transplanted rat hepatoma cells.
Kuramitsu Y; Nishibe M; Ohiro Y; Matsushita K; Yuan L; Obara M; Kobayashi M; Hosokawa M
Anticancer Drugs; 1997 Jun; 8(5):500-8. PubMed ID: 9215614
[TBL] [Abstract][Full Text] [Related]
8. Overcoming suppression of antitumor immune reactivity in tumor-bearing rats by treatment with bleomycin.
Xu ZY; Hosokawa M; Morikawa K; Hatakeyama M; Kobayashi H
Cancer Res; 1988 Dec; 48(23):6658-63. PubMed ID: 2460226
[TBL] [Abstract][Full Text] [Related]
9. Immunoregulatory cytokine release in rat spleen cell cultures after treatment with bleomycin and its analogues in vivo.
Micallef M; Hosokawa M; Shibata T; Nakane A; Yang ZB; Minagawa T; Kobayashi H
Cancer Immunol Immunother; 1991; 33(1):33-8. PubMed ID: 1708700
[TBL] [Abstract][Full Text] [Related]
10. Possible participation of tumoricidal macrophages in the therapeutic effect of bleomycin on a transplantable rat fibrosarcoma.
Morikawa K; Hosokawa M; Hamada J; Xu ZY; Kobayashi H
Cancer Res; 1986 Feb; 46(2):684-8. PubMed ID: 2416431
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide in depressed lymphoproliferative responses and altered cytokine production following thermal injury in rats.
Masson I; Mathieu J; Nolland XB; De Sousa M; Chanaud B; Strzalko S; Chancerelle Y; Kergonou JF; Giroud JP; Florentin I
Cell Immunol; 1998 Jun; 186(2):121-32. PubMed ID: 9665754
[TBL] [Abstract][Full Text] [Related]
12. Bleomycin but not its derivatives inhibits the in vivo shedding of a rat tumor-associated antigen.
Micallef M; Shibata T; Hosokawa M; Kobayashi H
Anticancer Drugs; 1992 Dec; 3(6):659-64. PubMed ID: 1283828
[TBL] [Abstract][Full Text] [Related]
13. Rat macrophage activation after treatment with the bleomycin group of antitumour antibiotics in vivo.
Micallef M; Hosokawa M; Togashi Y; Kobayashi H
Cancer Immunol Immunother; 1992; 35(2):106-12. PubMed ID: 1375871
[TBL] [Abstract][Full Text] [Related]
14. [Augmentation of antitumor immune responses by the antitumor antibiotic bleomycin].
Hosokawa M; Morikawa K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2700-8. PubMed ID: 6210061
[TBL] [Abstract][Full Text] [Related]
15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin co-stimulates staphylococcal enterotoxin beta (SEB) cytokine production and phenotypic cell cycling in Long-Evans rats.
Huang W; Koller LD
Int J Immunopharmacol; 1998; 20(1-3):39-56. PubMed ID: 9717081
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
17. Regulatory mechanisms for production of IFN-gamma and TNF by antitumor T cells or macrophages in the tumor-bearing state.
Yamamoto N; Zou JP; Li XF; Takenaka H; Noda S; Fujii T; Ono S; Kobayashi Y; Mukaida N; Matsushima K
J Immunol; 1995 Mar; 154(5):2281-90. PubMed ID: 7868900
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of intestinal and splenic cytokines after parenteral nutrition.
Ogle CK; Zuo L; Mao JX; Alexander JW; Fischer JE; Nussbaum MS
Arch Surg; 1995 Dec; 130(12):1301-7; discussion 1307-8. PubMed ID: 7492278
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS).
Akarid K; Pocidalo MA; Desforges B; Sinet M
Eur Cytokine Netw; 1995; 6(3):181-5. PubMed ID: 8589275
[TBL] [Abstract][Full Text] [Related]
20. A study of cytokine production in acute graft-vs-host disease.
Smith SR; Terminelli C; Kenworthy-Bott L; Phillips DL
Cell Immunol; 1991 May; 134(2):336-48. PubMed ID: 1902399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
